FridayJul 29, 2022 1:30 pm

QualityStocksNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Looking to Capitalize on Booming iGaming, Esports Markets

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, intends to capitalize on the burgeoning iGaming market expected to reach $127 billion by 2025 from $76.8 billion in 2020, buoyed by growth in Europe, the U.S. and Asia. “Golden Matrix’s GM-X system and newly launched GMX-Ag platform are a gold standard for the iGaming market, delivering access to 10,000+ games from over 25 leading providers. More than 635 unique casino operations use Golden Matrix’s platform to serve more than 7 million registered users. The company made its entrance into the lucrative European markets…

Continue Reading

FridayJul 29, 2022 12:25 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Growing Company Assets Amid Challenges to Markets

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) is reporting positive news amid challenges occasioned by inflationary pressures and shortages provoked by production problems and further exacerbated by the global COVID pandemic and now the war in Ukraine. “Eat Well’s portfolio includes protein alternative (non-meat) foods and natural baby food brands, and distribution agreements with Walmart, Whole Foods, Amazon and other companies,” a recent article reads. “Eat Well’s president and CEO Marc Aneed recently was interviewed by The Market Herald [Canada]’s reporters at The Power Play, discussing the company’s financial filings for Q1 2022, including the growth of its cash…

Continue Reading

ThursdayJul 28, 2022 12:21 pm

QualityStocksNewsBreaks – QSAM Biosciences Inc. (QSAM) Targeting Significant Unmet Medical Need with CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) is a company developing a new class of drugs called radiopharmaceuticals that deliver radiation therapy directly and specifically to cancer cells. The company’s lead drug candidate, CycloSam(R), is a clinical-stage bone-seeking radiopharmaceutical designed to deliver targeted radiation safely and precisely to tumors in the bone. “QSAM is leading the charge to evaluate a new treatment for bone cancer and other related, underserved diseases. The company’s pioneering efforts are evident as the first patient has completed treatment in the company’s clinical trial designed to study the effect of its proprietary radiopharmaceutical technology: CycloSam(R),” a recent article reads.…

Continue Reading

ThursdayJul 28, 2022 12:08 pm

QualityStocksNewsBreaks – FuelPositive Corporation’s (TSX.V: NHHH) (OTCQB: NHHHF) Ammonia Production System Designed to Eliminate Supply Chain Dependence, Stabilize Prices

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is driving the message that fossil fuels do not only damage the climate but also make the world economically vulnerable. This comes amid high fertilizer prices and the inherent presence and effects of climate change, factors threatening the rice production industry worldwide. “Carbon emissions are the leading cause of climate change and global warming issues worldwide. The company’s Hydrogen-Ammonia Synthesizer technology provides the means necessary to store green hydrogen as green ammonia that is completely carbon-free. The hydrogen can be removed when needed for use in fuel cells and other applications based on pure hydrogen…

Continue Reading

ThursdayJul 28, 2022 11:57 am

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Dedicating Strategy Toward Acquisition, Creation of Lifesaving Medical Products

Odyssey Health (OTC: ODYY) continues to dedicate its operational strategy toward the acquisition and creation of lifesaving medical products. “Odyssey’s portfolio includes medical device candidates and pharmaceutical products in development that are responsive to conditions such as heart disease, foreign object-induced choking, neurodegenerative disorders, and brain concussion injuries. One drug product designed to treat mild traumatic injury within the first few minutes after an incident is advancing in a phase 1 clinical human trial following on preclinical lab animal tests that provided encouraging data, CEO Michael Redmond said in a June interview,” a recent article reads. “No U.S. Food and…

Continue Reading

ThursdayJul 28, 2022 10:53 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO to Participate in Upcoming Canaccord Genuity Growth Conference

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be presenting at the 42nd annual Canaccord Genuity Growth Conference; the four-day event is scheduled for Aug. 8–11, 2022, in Boston. During the conference, Cybin CEO Doug Drysdale will present a fireside chat. Drysdale’s presentation is slated for Thursday, Aug. 11, 2022, at 3:30 p.m. ET. Interested individuals are invited to watch a live webcast of the event or an archived version of the event, available on the company’s investor relations page following the live presentation. To view the live presentation, visit https://ibn.fm/ghBjR To view…

Continue Reading

WednesdayJul 27, 2022 1:27 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Poised with Strong In-Market Brand Portfolio, Cultivation and Export Capabilities

Flora Growth Corp. (NASDAQ: FLGC) recently reported that its board of directors had authorized the repurchase of up to $5 million of its outstanding common shares. “These recent developments highlight Flora management’s confidence in where the company is headed and its potential for growth as the year progresses. It also assures shareholders of the company’s commitment to driving shareholder value and exploring various opportunities to do so. As such, this only emphasizes Flora’s value as a good investment,” a recent article reads. “While making the announcement, Luis Merchan, Flora’s chairman and CEO, noted: ‘Flora continues to move assertively to execute…

Continue Reading

WednesdayJul 27, 2022 1:13 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Making ‘Excellent Progress’ Toward Becoming Serious Network Participant

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network (“LN”), has launched 17 nodes internationally, positioning itself to secure future routing fees in the rapidly expanding global payments network. “LQwD’s international node selection now includes Canada, France, Italy, Indonesia, Japan, England, Bahrain, South Africa, South Korea, Sweden, Singapore, Brazil, Germany, India, Ireland, Hong Kong, and the U.S. LQwD launched its first node in November 2021, US-West, and since that time, it has amassed a capacity of 5.78671656 BTC (US$118,805.11),” a recent article reads. “Since launching our first Lightning…

Continue Reading

WednesdayJul 27, 2022 12:04 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD Hypertension Study Completes Dosing with No Serious Adverse Events

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing with its DehydraTECH(TM)-processed cannabidiol (“DehydraTECH-CBD”) has been completed in its multi-week human clinical hypertension study HYPER-H21-4. According to the update, no serious adverse events have been reported as a result of the dosing. “We are extremely pleased that dosing has been completed on time in this multi-week clinical study without any serious adverse events having occurred,” said Chris Bunka, CEO of Lexaria Bioscience Corp. “Demonstrating a noteworthy safety and tolerability profile relative to conventional anti-hypertensive medications is one of Lexaria’s major goals with this…

Continue Reading

WednesdayJul 27, 2022 11:04 am

QualityStocksNewsBreaks – DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Schedules Q2 2022 Earnings Call

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital social casino games, will hold a conference call at 5:00 p.m. ET on Tuesday, Aug. 9, to discuss its results for the second quarter ended June 30, 2022. Financial results will be issued in a press release prior to the call, which will feature a presentation hosted by DoubleDown management followed by a question-and-answer period. Interested parties should visit https://ibn.fm/FBdzl to register for the call. Upon registering, an email including dial-in details and a unique conference call access code will be sent to attendees. A simultaneous webcast of the…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered